Internal Medicine, Hematology & Oncology · Tallahassee, FL
NPI
1740383181
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1309 Thomaswood Dr
Tallahassee, FL, 32308
Phone (850) 727-8540
Groups this clinician bills Medicare through
Medicare paid, 2024
$892K
97,072 services
Medicare patients, 2024
172
Average age 75
Drug cost, 2024
$3.6M
1,414 prescriptions
Company payments, 2024
$6.11
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marie M Amanze was code J1756 (injection, iron sucrose, 1 mg), 10,000 times for 11 patients. In total Marie M Amanze billed 97,072 services in 92 codes, and Medicare paid $892K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-07-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 10,000 | 11 | $0.17 | $1,738 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,562 | 17 | $0.07 | $114 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,551 | 16 | $0.09 | $138 |
| J2916 Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | Office | 961 | 29 | $1.58 | $1,522 |
| 36415 Venipuncture Blood Collection | Office | 547 | 144 | $8.59 | $4,697 |
| J7050 Infusion, normal saline solution, 250 cc | Office | 534 | 55 | $0.51 | $271 |
| 85027 Blood Count | Office | 502 | 142 | $6.34 | $3,183 |
| 96367 Intravenous Infusion, Hydration | Office | 439 | 17 | $21.24 | $9,323 |
| 96372 Injection Administration | Office | 264 | 46 | $10.56 | $2,789 |
| 99214 Office E&M - Established | Office | 260 | 130 | $87.07 | $23K |
| 99213 Office E&M - Established | Office | 237 | 121 | $65.14 | $15K |
| 96365 Intravenous Infusion, Hydration | Office | 162 | 40 | $44.58 | $7,223 |
| 96413 Chemotherapy Administration | Office | 157 | 19 | $95.17 | $15K |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 118 | 29 | $0.92 | $109 |
| 96417 Chemotherapy Administration | Office | 105 | 13 | $46.97 | $4,932 |
By year: 2022 $1.1M for 71,810 services; 2023 $900K for 83,079 services; 2024 $892K for 97,072 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 547 | 144 | $8.59 | $4,697 |
| 85027 Blood Count | 502 | 142 | $6.34 | $3,183 |
| 85025 Blood Count | 57 | 46 | $7.21 | $411 |
Medicare prescription drug claims, 2024
In 2024, the drug Marie M Amanze prescribed most often to Medicare patients was Anastrozole, with 149 prescriptions and refills. In total Marie M Amanze wrote 1,414 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 149 | 286 | 31 | $2,221 |
| Eliquis Apixaban | 120 | 150 | 22 | $84K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 76 | 76 | 14 | $3,380 |
| Pomalyst Pomalidomide | 65 | 65 | Under 11 | $1.3M |
| Oxycodone Hcl Generic | 60 | 60 | 15 | $1,591 |
| Hydroxyurea Generic | 59 | 95 | 15 | $1,143 |
| Ondansetron Hcl Generic | 52 | 58 | 22 | $1,598 |
| Valacyclovir Valacyclovir Hcl | 46 | 74 | 13 | $1,769 |
| Morphine Sulfate Er Morphine Sulfate | 46 | 46 | Under 11 | $2,319 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 33 | 45 | 13 | $471 |
| Gabapentin Generic | 33 | 47 | 11 | $392 |
| Calquence Acalabrutinib Maleate | 30 | 30 | Under 11 | $450K |
| Lenalidomide Generic | 30 | 30 | Under 11 | $333K |
| Letrozole Generic | 26 | 62 | Under 11 | $740 |
| Xarelto Rivaroxaban | 26 | 38 | Under 11 | $20K |
Brand drugs: 377 claims; generic drugs: 1,037 claims; opioid claims: 244.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Marie M Amanze $6.11 ($6.11 in general payments such as food, travel and fees) from 1 company. The largest payer was Rigel Pharmaceuticals, Inc. with $6.11.
| Company | Payments | Amount |
|---|---|---|
| Rigel Pharmaceuticals, Inc. RIGL | 1 | $6.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.